Trials / Conditions / Pityriasis Rubra Pilaris
Pityriasis Rubra Pilaris
6 registered clinical trials studyying Pityriasis Rubra Pilaris — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Bimzelx (Bimekizumab) For The Treatment Of Adult Onset PRP NCT07497620 | Mayo Clinic | Phase 4 |
| Recruiting | Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris NCT06444399 | Mayo Clinic | Phase 2 |
| Completed | Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP) NCT03975153 | Oregon Health and Science University | Phase 2 |
| Completed | Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP) NCT03485976 | Oregon Health and Science University | Phase 2 |
| Completed | Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris NCT03342573 | Mayo Clinic | Phase 1 |
| Terminated | A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris NCT00815633 | Joshua Zeichner | Phase 4 |